JPWO2023104188A5 - - Google Patents

Info

Publication number
JPWO2023104188A5
JPWO2023104188A5 JP2024534514A JP2024534514A JPWO2023104188A5 JP WO2023104188 A5 JPWO2023104188 A5 JP WO2023104188A5 JP 2024534514 A JP2024534514 A JP 2024534514A JP 2024534514 A JP2024534514 A JP 2024534514A JP WO2023104188 A5 JPWO2023104188 A5 JP WO2023104188A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
set forth
sequence set
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024534514A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024545170A (ja
JP2024545170A5 (https=
Publication date
Priority claimed from PCT/CN2021/136994 external-priority patent/WO2023102875A1/en
Application filed filed Critical
Priority claimed from PCT/CN2022/137932 external-priority patent/WO2023104188A1/en
Publication of JP2024545170A publication Critical patent/JP2024545170A/ja
Publication of JPWO2023104188A5 publication Critical patent/JPWO2023104188A5/ja
Publication of JP2024545170A5 publication Critical patent/JP2024545170A5/ja
Pending legal-status Critical Current

Links

JP2024534514A 2021-12-10 2022-12-09 抗cdh6抗体及びその抗体薬物複合体 Pending JP2024545170A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN202111507685.5 2021-12-10
CNPCT/CN2021/136994 2021-12-10
CN202111507685 2021-12-10
PCT/CN2021/136994 WO2023102875A1 (en) 2021-12-10 2021-12-10 Anti-cdh6 antibody drug conjugate
PCT/CN2022/137932 WO2023104188A1 (en) 2021-12-10 2022-12-09 Anti-cdh6 antibodies and antibody-drug conjugates thereof

Publications (3)

Publication Number Publication Date
JP2024545170A JP2024545170A (ja) 2024-12-05
JPWO2023104188A5 true JPWO2023104188A5 (https=) 2025-12-08
JP2024545170A5 JP2024545170A5 (https=) 2025-12-08

Family

ID=86729685

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024534514A Pending JP2024545170A (ja) 2021-12-10 2022-12-09 抗cdh6抗体及びその抗体薬物複合体

Country Status (11)

Country Link
US (1) US20250090677A1 (https=)
EP (1) EP4444360A1 (https=)
JP (1) JP2024545170A (https=)
KR (1) KR20240130160A (https=)
CN (1) CN118302199A (https=)
AU (1) AU2022406708A1 (https=)
CA (1) CA3239715A1 (https=)
IL (1) IL313227A (https=)
MX (1) MX2024007035A (https=)
TW (1) TW202330618A (https=)
WO (1) WO2023104188A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2024190815A1 (https=) 2023-03-14 2024-09-19
TW202444427A (zh) 2023-03-31 2024-11-16 日商第一三共股份有限公司 抗CDH6抗體-藥物結合物與HIF-2α抑制劑之組合

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016169581A1 (en) * 2015-04-20 2016-10-27 Consejo Superior De Investigaciones Científicas Agents binding specifically to human cadherin-17, human cadherin-5, human cadherin-6 and human cadherin-20 rgd motif
WO2018185618A1 (en) * 2017-04-03 2018-10-11 Novartis Ag Anti-cdh6 antibody drug conjugates and anti-gitr antibody combinations and methods of treatment
TW202532102A (zh) * 2017-05-15 2025-08-16 日商第一三共股份有限公司 抗體-藥物結合物及其用途
JP7401456B2 (ja) * 2018-11-14 2023-12-19 第一三共株式会社 抗cdh6抗体-ピロロベンゾジアゼピン誘導体コンジュゲート

Similar Documents

Publication Publication Date Title
JP7401126B2 (ja) 抗cubドメイン含有タンパク質1(cdcp1)抗体、抗体薬物コンジュゲート、およびその使用方法
JP6333882B2 (ja) 抗体−薬剤コンジュゲート
JP2020527332A (ja) 抗−il1rap抗体および抗体薬物コンジュゲート
JP7827624B2 (ja) 抗cea抗体-エキサテカン類似体複合体及びその医薬用途
WO2023102875A1 (en) Anti-cdh6 antibody drug conjugate
CN110575548A (zh) 靶向于cd73的抗体-药物偶联物及其制法和用途
IL313227A (en) Anti-cdh6 antibodies and antibody-drug conjugates thereof
EP4374879A1 (en) Drug conjugate of eribulin derivative
US20240091372A1 (en) Anti-doppel antibody drug conjugates
EP4725968A1 (en) Anti-gpc3 antibody or antigen-binding fragment and use thereof
JPWO2023104188A5 (https=)
KR20250084935A (ko) 링커-페이로드 화합물, 접합체 및 이의 응용 분야
US12419964B2 (en) Antibody drug conjugate (ADC) targeting Nectin 4 and comprising an exatecan payload
US20260061066A1 (en) Anti-grp78 antibody, immunoconjugate and uses thereof
US20250019430A1 (en) Resistin-specific antibody and use thereof
CN121752296A (zh) 抗Doppel抗体药物偶联物
WO2025122988A2 (en) Engineered antibodies and immunoconjugates and methods of use
TW202432186A (zh) 配體-細胞毒藥物綴合物及其醫藥用途
WO2025194123A1 (en) Muc16/napi-2b antibodies and methods of use
KR20250174736A (ko) L1cam을 표적화하는 항체 및 이의 용도
HK40107995A (zh) 抗cdh6抗体及其抗体-药物偶联物